ReviewMicrobiome research reports2025
Immunomodulatory properties of dietary polyphenols: a role for combating infections at mucosal surfaces?
Review in Microbiome research reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antielastase and Antihyaluronidase Activity of Isomangiferin, a Xanthone with Strong Antioxidant Properties.International journal of molecular sciences · 2026Article
- Jabuticaba (Nutrients · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polyphenols are food components with antioxidant and anti-inflammatory properties, and their health benefits are increasingly recognized in the context of noncommunicable diseases such as type 2 diabetes. However, their role in regulating immunity to infection is not well understood. Here, we highlight the various mechanisms by which polyphenols may enhance mucosal immunity via both adaptive and innate immune responses. Polyphenols may directly interact with host receptors on mucosal epithelial and/or immune cells to regulate production of cytokines and antimicrobial peptides. They can also modify gut microbiota composition, yielding microbial-derived metabolites that play a key role in fine-tuning immune function at mucosal surfaces. We provide examples of how these immunological changes may alter the outcome of pathogen infection and propose that an increased understanding of polyphenol-microbiota-immune interaction will provide a framework for the application of new nutrition-based strategies in the management and prevention of infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.